XML 52 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments Measured at Fair Value (Tables)
12 Months Ended
Dec. 31, 2018
Fair Value Disclosures  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2018:
 
 
Balance Sheet Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (a)
 
Cash and cash equivalents / other assets
 
$
22,883

 
$

 
$

 
$
22,883

Equity investments (b)
 
Other assets
 
38,045

 

 

 
38,045

Interest rate swaps
 
Other liabilities
 

 
(589
)
 

 
(589
)
Foreign exchange contracts
 
Other current assets
 

 
4,163

 

 
4,163

Foreign exchange contracts
 
Accrued expenses
 

 
(2,384
)
 

 
(2,384
)
 
 
 
 
$
60,928

 
$
1,190

 
$

 
$
62,118



The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2017:
 
 
Balance Sheet Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (c)
 
Cash and cash equivalents / other assets
 
$
3,267

 
$
286,671

 
$

 
$
289,938

Equity investments (b)
 
Other assets
 
52,683

 

 

 
52,683

Interest rate swaps
 
Other liabilities
 

 
(149
)
 

 
(149
)
Foreign exchange contracts
 
Other current assets
 

 
5,499

 

 
5,499

Foreign exchange contracts
 
Accrued expenses
 

 
(8,581
)
 

 
(8,581
)
Contingent consideration
 
Accrued expenses
 

 

 
(3,176
)
 
(3,176
)
 
 
 
 
$
55,950

 
$
283,440

 
$
(3,176
)
 
$
336,214


(a)
Cash equivalents include highly liquid investments with an original maturity of less than three months.
(b)
The company has an 8.4% equity ownership interest in Marubun Corporation and a portfolio of mutual funds with quoted market prices. During 2018, 2017, and 2016 the company recorded unrealized gains (losses) of $(13,693), $14,651, and $(4,064), respectively, on equity securities held at the end of each year.
(c)
Cash equivalents at December 31, 2017 included $286,671 invested in certificates of deposit, with an original maturity of less than three months, held in anticipation of our acquisition of eInfochips, which closed in January 2018 (see Note 2).
Description of Types of Interest Rate Fair Value Hedging Instruments Used The terms of outstanding interest rate swap contracts at December 31, 2018 are as follows:
Maturity Date
 
Notional Amount
 
Interest rate due from counterparty
 
Interest rate due to counterparty
April 2020
 
50,000
 
6.000%
 
6 mo. USD LIBOR + 3.896
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block] The effects of derivative instruments on the company's consolidated statements of operations and other comprehensive income are as follows for the years ended December 31:
 
 
2018
 
2017
 
2016
Gain (Loss) Recognized in Income
 
 
 
 
 
 
Foreign exchange contracts
 
$
6,940

 
$
(20,877
)
 
$
1,535

Interest rate swaps
 
(1,236
)
 
(831
)
 
(608
)
Total
 
$
5,704

 
$
(21,708
)
 
$
927

Loss Recognized in Other Comprehensive Income before reclassifications
 
 
 
 
 
 
Foreign exchange contracts
 
$
(409
)
 
$
(2,022
)
 
$
(153
)
Interest rate swaps
 

 
(4,672
)
 

Total
 
$
(409
)
 
$
(6,694
)
 
$
(153
)